Core Viewpoint - In 2024, Jiangsu Bank demonstrated robust performance amidst challenges such as declining interest rates and narrowing spreads, achieving significant growth in revenue and net profit while maintaining strong asset quality and risk management capabilities [1][2][3]. Financial Performance - Jiangsu Bank reported total assets of 3.95 trillion yuan, a year-on-year increase of 16.12% [2] - The bank's total revenue reached 80.815 billion yuan, up 8.78% year-on-year, with a net profit attributable to shareholders of 31.843 billion yuan, reflecting a 10.76% increase [2] - The annualized return on equity (ROE) was 13.59%, and the annualized return on assets (ROA) was 0.91%, placing the bank in the top tier of the industry [2] Revenue Structure - The bank's net interest income was 55.957 billion yuan, a 6.29% increase, accounting for 69% of total revenue [3] - Non-interest income reached 24.858 billion yuan, growing by 14.83%, indicating successful transformation towards light capital operations [3] - Despite industry-wide pressures, Jiangsu Bank maintained a net interest margin of 1.86%, which, although down 12 basis points from the previous year, remained above the industry average [3] Support for the Real Economy - Jiangsu Bank plays a crucial role in supporting the local economy, particularly in technology finance, with a technology loan balance of 232.6 billion yuan, growing by 22.8% [4] - The bank has established a service base for corporate listings and optimized its service system for technology enterprises [4] Green Finance Initiatives - The bank has developed a leading green finance brand, with green financing reaching 550.9 billion yuan, a 22.4% increase [5] - Jiangsu Bank has introduced various green financial products and actively participates in ESG development initiatives [5] Retail Banking and Wealth Management - Jiangsu Bank's retail assets under management (AUM) exceeded 1.42 trillion yuan, maintaining the top position among city commercial banks [7] - The bank's retail deposit balance grew by 16.21% to 822.9 billion yuan, while retail loans increased by 3.40% to 674.8 billion yuan [7] Risk Management - The non-performing loan (NPL) ratio decreased to 0.89%, the lowest since the bank's listing, with a provision coverage ratio of 350.10%, significantly above the industry average [9] - The bank has implemented a comprehensive risk management system to enhance its risk control capabilities [9][10] Market Performance - Jiangsu Bank's stock price rose by over 56% in 2024, closing at 9.82 yuan per share, with a total market capitalization exceeding 180 billion yuan, ranking first among city commercial banks [13][14] - The bank has maintained a cash dividend payout ratio of 30%, distributing 9.554 billion yuan in cash dividends for 2024 [14]

买榴莲就像开盲盒，不知道是报恩的还是报仇的？4月18日，随着A+级泰国金枕鲜满分榴莲全面上市， 京东七鲜也正式发布行业首个"满分榴莲标准"，从房数、出肉率、成熟度等多个维度进行了严格的规 定，同步针对A+级泰国金枕鲜满分榴莲推出包含保4大房、保出肉率30%-35%、保熟的"三保服务"。京 东七鲜在重塑榴莲行业标准的同时，更重要的是为消费者带来"又好又便宜"的榴莲购买体验。 不同于一般水果，榴莲对生长环境、采摘后对运输条件要求极为苛刻，稍有不慎就可能出现成熟度失控 的情况。但京东七鲜敢于重新定义满分榴莲标准并带来A+级泰国金枕鲜满分榴莲的背后，是其依托"产 地直采"模式，从泰国东部和南部精心挑选优质的果园，并由拥有多年经验的水果专家严格按照京东七 鲜A+级标准挑选果实，同时通过提升供应链效率压缩中间环节成本，打破传统即时零售模式中"品质、 价格、速度"三者无法兼得的"不可能三角"，真正做到"又好又便宜"。 此次，京东七鲜推出的"满分榴莲标准"，不仅是对消费者的品质承诺，更是对行业的重塑，推动市场 从"价格战"迈向"品质战"。4月18日起，消费者登录京东七鲜APP或前往全国七鲜门店，即可选购A+级 泰国金枕鲜满分 ...

4月17日晚间，杭州景业智能科技股份有限公司(简称"景业智能"或"公司"，代码：688290.SH)发布2024 年年度报告和2025年第一季度报告。 2024年，景业智能在特种机器人及智能装备领域持续深耕，整体经营稳中向好，整年实现营业收入2.76 亿元，同比增长7.94%；归属于上市公司股东的净利润为3,760万元，同比增长8.4%；扣非净利润为 1,718万元，同比增长5.67%。 2025年第一季度，公司主营收入2150.52万元，同比下降7.54%；归母净利润-990.34万元，同比上升 11.37%；扣非净利润-1346.57万元，同比上升5.53%。 行业前景广阔，"核+军+民"战略布局稳步推进 整体来看，近六年我国工业机器人产量呈先升后降再升走势。据中商产业研究院与观研报告网数据显 示，2024年1-12月我国工业机器人产量累计约为556369套，同比增长14.2%；2024年12月我国工业机器 人产量约为71382套，环比增长24.9%。 图源：观研报告网 同时，2024年国产机器人销量占比预计将提升至55.63%，充分彰显出国产机器人技术性能的进步。随 着国家加码对核能、国防军工等战略性新 ...

4月10日-12日，由中关村储能产业技术联盟、中国能源研究会、中国科学院工程热物理研究所联合主办 的第十三届储能国际峰会暨展览会在北京落下帷幕。展会以"数智赋能产业变革，储能重塑能源格局"为 主题，涵盖了储能产业链的各个环节，吸引了行业内众多知名企业的参与。永福数能携四大平台、五大 系统、三大硬件精彩亮相本次国际储能盛会，与来自全球超800家储能领军企业共商储能行业发展之 路。 数智产品 匠心呈现 近年来，永福数能聚焦"数字储能、数字新能源、数字电网"三大业务领域，深度融合电力监控、大数 据、人工智能、物联网、5G等前沿数智技术，自主打造EMS能源管理系统和"永福云"能源大数据平 台，为客户提供覆盖新能源、储能、电网及源网荷储一体化等多样化应用场景的智慧解决方案和产品。 本次展会全新推出"微电网及综合能源管理系统"、"新能源大数据平台"和专为聚合商设计的"虚拟电厂 大数据平台"，吸引了众多参观者的目光，并得到了现场专业人士的一致好评。 微电网及综合能源管理系统：集成数据采集、实时监控、智能分析等核心功能，并提供高级控制策略定 制、智能诊断预警、全景数据分析等增值服务。该解决方案已在中国及东南亚地区成功落地，显 ...

活动现场，许多健康养老好物也与老人们见面。鱼跃电动轮椅轻便灵活，三诺电子血压仪伸手即测，科 大讯飞助听器、迈德斯特电动护理床、医仑特折叠洗澡椅等适老健康产品，让老年人获得便捷舒适的产 品体验。同时，老金磨方黑芝麻丸、银善存多维元素片等健康产品也让老年人有了更多选择。此外，京 东健康的皮肤检测、春季流感检测、护士到家中医按摩调理服务等项目，也被更多活动参与者所了解。 随着我国老龄化进程的加速，银发经济正成为社会关注的焦点。为了更好地服务老年群体，倡导健康养 老的生活方式，4月15日，京东健康在北京陶然亭公园举办了一场别开生面的"老友迎春会"。此次活动 不仅为老年人提供了一个集健康服务、娱乐互动和社交于一体的场合，更是京东健康在推动健康养老产 业高质量发展方面的一次积极探索。 "老友迎春会"精彩纷呈 活动被"点赞" 活动当天，陶然亭公园洋溢着活力与温暖。活动现场设置了多个板块，将健康服务、互动游戏、文艺表 演和养老产品体验有机融合，为老年人带来一场丰富多彩的春日盛会。 在健康服务方面，由三甲医院医生、心理咨询师、京东健康全职营养师、京东护士到家服务团队、之业 堂推拿正骨医师等组成的京东健康专家团，为老年人提供免费 ...

Core Insights - The launch of Xinotong® (Roxadustat) and Qingwanrui® (Regorafenib) on JD Health marks a significant advancement in treatment options for patients with chronic kidney disease anemia and cancer [1][2][3] - Chronic kidney disease is a major public health issue in China, with anemia being a common complication that worsens patient outcomes [1] - The introduction of these new drugs addresses unmet clinical needs, providing innovative treatment solutions for patients [1] Group 1: Product Details - Xinotong® (Roxadustat) is approved for use in chronic kidney disease-related anemia, suitable for both dialysis and non-dialysis patients, and offers advantages such as oral administration and improved iron utilization [2] - Qingwanrui® (Regorafenib) is an oral multi-target receptor tyrosine kinase inhibitor, effective in treating second-line liver cancer and third-line colorectal cancer, recommended by various clinical guidelines [2] Group 2: Market Impact - JD Health's strategy of being the first platform to launch new specialty drugs enhances its market position and expands access to high-quality medications for patients [3] - The collaboration with Nanjing Zhengda Tianqing not only diversifies JD Health's product offerings but also strengthens its online sales channels for cost-effective treatments [3] - Future collaborations with pharmaceutical companies are anticipated to explore new treatment pathways, aiming to provide hope and improved outcomes for more patients [3]

近期，南玻A(00012)披露首次回购进展。公告显示，2025年4月2日，公司首次通过A股股份回购专 用证券账户以集中竞价方式回购公司A股股份385,000股。2025年4月10日，公司首次通过B股股份回购 专用证券账户以集中竞价方式回购公司B股股份158,400股。 据南玻A此前公告，公司拟使用自有资金和自筹资金(含商业银行回购专项贷款等)对A股、B股进行 回购。其中用于回购A股的资金总额不低于2.43亿元人民币，且不超过4.85亿元人民币；用于回购的B股 资金总额不低于5000万港元，且不超过1亿港元。 由此可见，公司不仅坚定看好中国经济发展前景，而且对自身未来发展前景充满信心。真金白银回 购股票向资本市场传递积极信号，增强了投资者信心，也有效维护了广大投资者的利益。 真金白银表达对经济发展的坚定看好 4月以来，央企、地方国企、上市公司密集发布增持、回购、资产注入、提高分红比例计划或进 展，集体提振投资者信心，甚至有不少上市公司罕见表示将"加快回购""加快增持"，充分体现了对中国 经济长期向好的坚定信心。 根据Wind数据，上周(4月6日至4月12日)共有134家A股上市公司实施回购，回购总金额达49.7 ...

整合百家肿瘤医院资源满足患者多样化需求 4月15日-21日是第31个全国肿瘤防治宣传周。今年活动的主题是"科学防癌健康生活",为了给肿瘤患者提 供更优质、可及的医疗服务资源,今年肿瘤防治宣传周期间,京东互联网医院肿瘤专科全面升级,整合全国 百家肿瘤医院的知名专家,为肿瘤患者提供加号问诊、报告解读、诊疗方案推荐、诊后管理等全病程一 站式医疗服务,极大提高患者就医的便捷性和可及性。这也是京东互联网医院在互联网专科医疗体系迈 出的重要一步。 联动行业生态共建探索肿瘤管理新模式 随着肿瘤患者的治疗需求日益增长,对高效、安全、便捷的肿瘤药品与营养供应渠道也提出了更高要 求。多年来,依托自身强大的供应链优势,京东健康与全球知名药企深化合作,汇聚了400余款肿瘤治疗药 物,涵盖肺癌、乳腺癌、肝癌、胃癌等全癌种,累计为200万肿瘤患者提供专业、可及的药品服务。 今年以来,京东健康持续巩固"新特药全网首发第一站"的优势,通过成熟的新药推广方案,帮助正大天晴药 业集团旗下的依维莫司片(晴维时)、富马酸安奈克替尼胶囊(安柏尼)等五款肿瘤药品在京东健康独家首 发。这些药品覆盖从晚期乳腺癌、晚期肾癌到非小细胞肺癌等多种癌症类型,切实提 ...

Group 1 - S&P Global released the "Sustainability Yearbook (China Edition) 2025," recognizing Fosun International for its ongoing efforts in ESG, marking its second consecutive year in the top 1% [1][4] - Over 1,600 Chinese companies were evaluated for the yearbook, with only about 160 achieving the honor, requiring a CSA score in the top 15% of their industry [4] - Fosun International achieved a CSA score of 70, significantly surpassing the industry average by nearly 40 points, ranking in the top 5% globally as of April 2025 [4] Group 2 - Fosun International has consistently received high ESG ratings, maintaining an MSCI ESG rating of AA since 2021, and an AA- rating from Hang Seng, while being included in the FTSE4Good Index Series [6] - The company has established a comprehensive ESG management system, integrating ESG requirements into its operations and addressing key social issues through various initiatives [6] - Looking ahead, Fosun aims to deepen its industry engagement, enhance innovation, and promote sustainable business development to create long-term value for stakeholders [6]

Group 1 - Microbull's stock price surged over 10% to $13.25 on its first trading day after going public via DE-SPAC on Nasdaq, and on the second trading day, it experienced a peak increase of over 500%, closing up 374.7% with a total market capitalization of $29.6 billion [1] - GIBO, a Malaysian AI company specializing in AIGC animation streaming, is set to go public soon, with an estimated pre-IPO valuation of approximately $8.28 billion, and is expected to perform well in the market following Microbull's success [1] - GIBO's advanced AIGC technology and broad market prospects are anticipated to generate significant market interest post-IPO, potentially leading to rapid growth in its market capitalization [1] Group 2 - Zhongda Group Holdings has fully transitioned into the AI sector and is becoming a significant player in the Hong Kong AI market, holding shares in GIBO and actively participating in its media relations and content ecosystem development [2] - As GIBO progresses towards its IPO and its market value increases, the value of Zhongda Group Holdings' shares in GIBO is expected to rise significantly, enhancing its financial performance and asset quality [2] - The capital appreciation from GIBO's success will strengthen Zhongda Group Holdings' influence and competitiveness in technology investments, positioning the company for long-term growth in the tech revolution [2]